Bruush Competitors

Delisted . USA . 
Stock . Bruush Oral Care
BRSHDelisted Stock  USD 0.0005  0.0001  16.67%   
Bruush Oral Care competes with European Wax, Edgewell Personal, Inter Parfums, Henkel AG, and Yoshitsu; as well as few others. The company conducts business under Personal Care Products sector and is part of Consumer Staples industry. Analyzing Bruush Oral competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bruush Oral to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bruush Oral competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bruush Oral's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00060.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00050.00
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.00030.00090
Details

Bruush Oral Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bruush Oral and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Bruush and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bruush Oral Care does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
YSG
+ 0.9
IPAR
YSG
+ 0.77
NTCO
HELKF
+ 0.7
EWCZ
NTCO
+ 0.63
IPAR
TKLF
+ 0.58
HELKF
TKLF
+ 0.45
EWCZ
  
High negative correlations   
TKLF
- 0.91
NTCO
YSG
- 0.83
TKLF
TKLF
- 0.71
IPAR
YSG
- 0.66
HELKF
HELKF
- 0.59
IPAR
YSG
- 0.53
EWCZ

Risk-Adjusted Indicators

There is a big difference between Bruush Stock performing well and Bruush Oral Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bruush Oral's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Bruush Oral Competitive Analysis

The better you understand Bruush Oral competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bruush Oral's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bruush Oral's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BRSH EWCZ EPC IPAR HELKF NTCO TKLF YSG
 16.67 
 0.0005 
Bruush
 3.25 
 6.04 
European
 0.25 
 35.37 
Edgewell
 0.51 
 136.84 
Inter
 2.89 
 79.11 
Henkel
 3.30 
 7.52 
Natura
 3.31 
 3.80 
Yoshitsu
 3.05 
 4.77 
Yatsen
Market Volatility
(90 Days Market Risk)
Very steady
Slightly risky
Very steady
Very steady
Very steady
Very steady
Very risky
Relatively risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
OK
Very Weak
Very Weak
Very Weak
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Very Small
Very Low
Very Low
Low
Dangerous
Very Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Strong Buy
Not Available
Not Available
Strong Sell
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Strong Hold
Strong Hold
Cautious Hold
Not Rated
Strong Sell
Strong Hold
Current Ratio
0.21 X
2.57 X
1.62 X
2.89 X
1.04 X
1.30 X
1.83 X
5.47 X
Net Asset
1.19 M
735.73 M
3.73 B
1.37 B
32.67 B
54.69 B
142.92 M
5.01 B
Profit Margin
(2.57) %
0.06 %
0.04 %
0.11 %
0.05 %
0.14 %
0.04 %
(0.27) %
EBITDA
(10.49 M)
65.44 M
285.4 M
280.98 M
3.18 B
2.2 B
1.89 B
(355.91 M)
Operating Margin
(5.29) %
0.24 %
0.1 %
0.25 %
0.1 %
(0.01) %
0.04 %
(0.17) %
Current Valuation
2.51 M
603.13 M
2.81 B
4.44 B
31.04 B
10.44 B
74.46 M
308.02 M
Price To Book
N/A
3.91 X
1.09 X
5.63 X
1.37 X
0.79 X
0.45 X
0.94 X
Retained Earnings
(26.39 M)
(109.51 M)
1.09 B
693.85 M
13.73 B
(1.99 B)
21.07 M
(7.35 B)
Current Asset
N/A
N/A
1.45 B
468.76 M
8.96 B
9.39 B
N/A
N/A
Five Year Return
N/A
N/A
N/A
1.49 %
N/A
N/A
N/A
N/A
Beta
N/A
1.23
0.86
1.17
0.56
1.27
0.077
-2.82
Number Of Employees
11
120
6.7 K
607
51.8 K
16
140
1.5 K
Shares Outstanding
100.97 M
44.76 M
48.72 M
32.03 M
259.8 M
690.42 M
4.22 M
68.53 M
Cash Flow From Operations
(12.59 M)
55.6 M
231 M
105.77 M
2.14 B
(1.37 B)
1.9 M
(107.44 M)
Annual Yield
N/A
N/A
0.02 %
0.02 %
0.03 %
0.04 %
N/A
N/A
Total Debt
2.59 M
380.39 M
1.3 B
192.37 M
1.54 B
16.86 B
9.85 B
113.23 M
Return On Equity
N/A
0.14
0.0631
0.2
0.0581
-0.0775
0.23
-0.2
Z Score
N/A
N/A
N/A
N/A
11.4
N/A
N/A
N/A
Return On Asset
-5.77
0.0428
0.0431
0.11
0.0406
0.0118
0.0223
-0.0844
Number Of Shares Shorted
2.22 M
1.97 M
2.03 M
763.39 K
N/A
788.05 K
249.85 K
965.22 K
Book Value Per Share
(10.12) X
1.72 X
32.20 X
24.30 X
46.98 X
20.30 X
0.85 X
38.39 X
Current Liabilities
N/A
N/A
868.2 M
131.08 M
8.01 B
7.62 B
N/A
N/A
Total Asset
1.19 M
735.73 M
3.73 B
1.37 B
32.67 B
54.69 B
142.92 M
5.01 B
Short Ratio
0.05 X
6.74 X
4.95 X
4.71 X
N/A
0.69 X
2.68 X
3.13 X
Debt To Equity
N/A
2.84 %
0.96 %
0.22 %
0.18 %
0.68 %
1.45 %
0.05 %
Target Price
N/A
8.56
41.88
142.6
N/A
7.71
N/A
4.07
Last Dividend Paid
N/A
N/A
0.6
2.88
1.85
N/A
N/A
N/A
Shares Owned By Institutions
12.96 %
97.69 %
96.34 %
58.84 %
13.00 %
4.18 %
0.84 %
17.00 %
Market Capitalization
8.68 M
343.94 M
1.72 B
4.38 B
30.03 B
4.63 B
16.04 M
470.12 M
Price To Earnings To Growth
N/A
0.32 X
2.39 X
2.73 X
1.86 X
(16.12) X
N/A
N/A
Price To Earning
N/A
N/A
35.85 X
75.69 X
17.11 X
31.99 X
14.67 X
N/A
Price To Sales
2.97 X
1.54 X
0.76 X
3.09 X
1.39 X
0.13 X
0.08 X
0.14 X
Net Income
(8.77 M)
8.93 M
98.6 M
152.65 M
1.63 B
4.75 B
7.48 M
(750.23 M)
Earnings Per Share
(14.67) X
0.23 X
1.97 X
4.67 X
2.81 X
(0.58) X
2.00 X
(1.13) X
Shares Owned By Insiders
17.35 %
0.73 %
4.27 %
43.64 %
61.80 %
N/A
67.00 %
N/A
Revenue
2.63 M
221.02 M
2.25 B
1.32 B
20.07 B
34.84 B
195.68 M
3.41 B
Working Capital
(1.41 M)
57.67 M
372.4 M
514.28 M
951 M
2.78 B
4.35 B
2.34 B
Cash And Equivalents
N/A
31.19 M
216.4 M
195.88 M
1.92 B
4.28 B
17.67 M
3.14 B
Cash Per Share
N/A
0.79 X
3.50 X
6.15 X
4.44 X
6.23 X
0.49 X
5.06 X
Gross Profit
1.76 M
148.12 M
937.9 M
607.42 M
9.07 B
23.19 B
39.05 M
2.52 B
Day Typical Price
6.0E-4
6.01
35.32
136.44
79.11
7.44
3.83
4.83
Accumulation Distribution
0.29
0.0677
0.0127
0.0196
N/A
0.0384
0.0581
0.0541
Market Facilitation Index
2.0E-4
0.42
0.45
2.7
N/A
0.29
0.23
0.27
Daily Balance Of Power
(0.50)
0.4524
(0.20)
(0.26)
9.2 T
0.8276
(0.57)
(0.56)
Period Momentum Indicator
(0.0001)
0.19
(0.09)
(0.70)
2.22
0.24
(0.13)
(0.15)
Rate Of Daily Change
0.83
1.03
1.0
0.99
1.03
1.03
0.97
0.97
Day Median Price
6.0E-4
5.99
35.3
136.24
79.11
7.4
3.85
4.86
Price Action Indicator
(0.0001)
0.15
0.03
0.25
1.11
0.23
(0.11)
(0.16)
Relative Strength Index
24.74
44.43
67.5
74.12
27.65
59.6
41.17
78.57
Coefficient Of Variation
1909.1
(5,824)
(5,709)
599.76
(14,621)
342.48
(1,653)
525.91
Mean Deviation
30.88
2.82
1.12
1.28
0.5579
2.47
5.14
2.27
Jensen Alpha
3.57
(0.25)
(0.12)
0.171
(0.02)
0.9932
(0.35)
0.5064
Total Risk Alpha
(4.48)
(0.63)
(0.21)
0.0605
(0.23)
0.5534
(1.36)
0.1974
Sortino Ratio
0.0879
N/A
N/A
0.0917
N/A
0.3342
N/A
0.156
Downside Variance
1293.12
N/A
N/A
3.71
N/A
6.94
N/A
10.23
Standard Deviation
62.24
4.35
1.44
1.66
1.68
3.36
7.3
3.15
Kurtosis
25.57
11.19
(0.02)
0.5903
15.1
3.91
2.03
1.92
Potential Upside
90.91
6.89
2.65
2.61
2.96
5.72
12.41
5.71
Treynor Ratio
(0.92)
(0.05)
(0.04)
0.2511
0.9682
(3.91)
0.4002
0.6438
Maximum Drawdown
465.38
31.55
6.5
8.04
12.85
20.38
41.77
19.81
Variance
3874.29
18.94
2.08
2.76
2.82
11.28
53.36
9.92
Market Risk Adjusted Performance
(0.91)
(0.04)
(0.03)
0.2611
0.9782
(3.90)
0.4102
0.6538
Risk Adjusted Performance
0.0479
(0)
(0.01)
0.1265
7.0E-4
0.2196
(0.03)
0.1456
Skewness
4.26
(2.11)
(0.01)
(0.70)
(2.57)
1.19
(0.62)
0.4019
Semi Deviation
29.46
N/A
N/A
1.63
N/A
1.76
N/A
2.32
Information Ratio
0.0508
(0.04)
(0.09)
0.1064
(0.07)
0.2622
(0.07)
0.1584
Value At Risk
(58.43)
(4.72)
(2.73)
(2.75)
(0.12)
(4.03)
(14.23)
(4.11)
Expected Short fall
(54.11)
N/A
N/A
(1.29)
N/A
(3.00)
N/A
(2.51)
Downside Deviation
35.96
N/A
N/A
1.93
N/A
2.64
N/A
3.2
Semi Variance
868.15
N/A
N/A
2.66
N/A
3.11
N/A
5.38

Bruush Oral Competition Performance Charts

Five steps to successful analysis of Bruush Oral Competition

Bruush Oral's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bruush Oral Care in relation to its competition. Bruush Oral's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bruush Oral in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bruush Oral's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bruush Oral Care, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bruush Oral position

In addition to having Bruush Oral in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Bruush Stock

If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY